Drug and pharmaceutical composition for the treatment of muscles
AssigneeSociete Valbiofrance
InventorsDenis Barritault, Jean-Pierre Caruelle, Pascal Desgranges, Jean Gautron, Anne Meddahi
Life of this patent
Estimating the term…
Abstract
Use of at least one polymer or one biopolymer, called HBGFPP, specifically protecting the growth factors of the FGF and beta TGF families from tryptic degradation in the manufacture of a drug for the treatment of muscular tissues.
Claims14
A method for treating skeletal or cardial muscular tissue in a mammal, which comprises administering to the mammal a therapeutically effective amount of a polymer or bipolymer which is a HBGFPP (heparin binding growth factor protector and promoter).
A method of treating skeletal or cardiac muscular tissue, which comprises administering to a human or other animal in need of such therapy an effective amount of a pharmaceutical composition containing a) a therapeutically effective amount of at least one polymer or biopolymer, which is a HBGFPP (heparin binding growth factor protector and promoter), which specifically protects the growth factors of families of FGFs and beta TGFs from tryptic degradation and does not significantly inhibit coagulation, in association with b) at least one pharmacologically acceptable excipient.
Dependencies are inferred from the claim text.